TGFB1I1 have been verified to be acted as an oncogene in several cancers, including esophageal squamous cell carcinoma (35), breast tumor (36), ovarian cancer (37), and osteosarcoma (38). This evidence concerns the gene TGFB1I1 and breast neoplasm.